Largest health care pharmaceutical companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 61 health care pharmaceutical companies ranked by earnings, at CHF 22.6B, ahead of Eli Lilly (CHF 17.4B) and Merck & Co (CHF 15.4B). Figures as of 19 Nov 2026, 15:08 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonCHF 22.6B
- Median
- CHF 49.8M
- Combined market value
- CHF 4.21T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | CHF 22.6B | CHF 541.7B | CHF 225.02 | 2.21% down | 34% up | ||
| 2 | Eli LillyLLY · Health Care | CHF 17.4B | CHF 1.03T | CHF 1,153.05 | 1.18% down | 33% up | ||
| 3 | Merck & CoMRK · Health Care | CHF 15.4B | CHF 280.4B | CHF 113.73 | 2.18% down | 45% up | ||
| 4 | Novo NordiskNVO · Health Care | CHF 12.8B | CHF 145.8B | CHF 33.09 | 0.56% down | 17% down | ||
| 5 | NovartisNVS · Health Care | CHF 11.8B | CHF 241.3B | CHF 127.77 | 2.44% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | CHF 8.6B | CHF 230B | CHF 148.27 | 1.71% down | 1% up | ||
| 7 | SanofiSNY · Health Care | CHF 7.3B | CHF 91.9B | CHF 38.29 | 3.71% down | 4% down | ||
| 8 | PfizerPFE · Health Care | CHF 6.6B | CHF 132.3B | CHF 23.21 | 2.00% down | 15% up | ||
| 9 | GSKGSK · Health Care | CHF 6.4B | CHF 80.9B | CHF 40.38 | 1.50% down | 5% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | CHF 6B | CHF 100.8B | CHF 49.31 | 1.89% down | 30% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | CHF 5.5B | CHF 153.2B | CHF 88.43 | 0.30% up | 16% down | ||
| 12 | Regeneron PharmaceuticalsREGN · Health Care | CHF 3.8B | CHF 81.1B | CHF 783.71 | 1.78% down | 28% up | ||
| 13 | AbbVieABBV · Health Care | CHF 3.6B | CHF 421.6B | CHF 238.54 | 1.16% down | 25% up | ||
| 14 | Vertex PharmaceuticalsVRTX · Health Care | CHF 3.3B | CHF 114.1B | CHF 450.06 | 0.58% down | 27% up | ||
| 15 | ZoetisZTS · Health Care | CHF 2.3B | CHF 28.2B | CHF 69.43 | 3.84% down | 26% down | ||
| 16 | Teva Pharmaceutical IndustriesTEVA · Health Care | CHF 1.2B | CHF 40B | CHF 34.25 | 3.88% down | 74% up | ||
| 17 | United TherapeuticsUTHR · Health Care | CHF 1.1B | CHF 20.5B | CHF 480.99 | 1.27% down | 22% up | ||
| 18 | GenmabGMAB · Health Care | CHF 812.6M | CHF 27.2B | CHF 44.06 | 2.43% up | 70% up | ||
| 19 | Royalty PharmaRPRX · Health Care | CHF 650.6M | CHF 33.1B | CHF 57.58 | 0.63% down | 79% up | ||
| 20 | PTC TherapeuticsPTCT · Health Care | CHF 576M | CHF 4.2B | CHF 50.85 | 0.05% up | 21% down | ||
| 21 | Dr. Reddy's LaboratoriesRDY · Health Care | CHF 384.8M | CHF 10.4B | CHF 12.52 | 0.93% down | 8% up | ||
| 22 | TG TherapeuticsTGTX · Health Care | CHF 377.3M | CHF 8.5B | CHF 56.53 | 1.32% up | 117% up | ||
| 23 | GrifolsGRFS · Health Care | CHF 376.4M | CHF 4.8B | CHF 7.06 | 1.24% down | 0% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | CHF 294.4M | CHF 10.4B | CHF 53.63 | 3.45% up | 17% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | CHF 264.8M | CHF 16.9B | CHF 126.40 | 0.26% up | 66% down | ||
| 26 | BeOne MedicinesONC · Health Care | CHF 242.1M | CHF 38.7B | CHF 338.75 | 0.54% down | 16% up | ||
| 27 | AlkermesALKS · Health Care | CHF 203.9M | CHF 6.6B | CHF 39.10 | 1.11% down | 66% up | ||
| 28 | Ligand PharmaceuticalsLGND · Health Care | CHF 105M | CHF 5B | CHF 249.25 | 1.12% down | 50% up | ||
| 29 | Corcept TherapeuticsCORT · Health Care | CHF 84.1M | CHF 6.2B | CHF 56.55 | 1.15% down | 10% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | CHF 60.8M | CHF 6.4B | CHF 18.24 | 1.23% down | 90% up | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CHF 49.8M | CHF 6.3B | CHF 80.07 | 0.17% down | 129% up | ||
| 32 | Arrowhead PharmaceuticalsARWR · Health Care | -CHF 1.4M | CHF 5.3B | CHF 37.17 | 2.18% up | 13% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | -CHF 19.7M | CHF 5.2B | CHF 78.90 | 1.09% up | 34% up | ||
| 34 | Travere TherapeuticsTVTX · Health Care | -CHF 21.6M | CHF 4.1B | CHF 42.87 | 1.11% up | 45% up | ||
| 35 | VeradermicsMANE · Health Care | -CHF 59.1M | CHF 4.6B | CHF 107.86 | 2.37% up | 231% up | ||
| 36 | Belite BioBLTE · Health Care | -CHF 65.5M | CHF 5.3B | CHF 130.87 | 0.73% down | 43% up | ||
| 37 | Oruka TherapeuticsORKA · Health Care | -CHF 89M | CHF 5.8B | CHF 85.58 | 5.93% up | 255% up | ||
| 38 | ErascaERAS · Health Care | -CHF 105.1M | CHF 4.3B | CHF 12.22 | 5.23% up | 395% up | ||
| 39 | Protagonist TherapeuticsPTGX · Health Care | -CHF 109.8M | CHF 7B | CHF 107.89 | 0.55% up | 51% up | ||
| 40 | Spyre TherapeuticsSYRE · Health Care | -CHF 131M | CHF 8.1B | CHF 84.95 | 0.78% down | 332% up | ||
| 41 | Dianthus TherapeuticsDNTH · Health Care | -CHF 137M | CHF 4.1B | CHF 72.70 | 2.58% up | 108% up | ||
| 42 | Edgewise TherapeuticsEWTX · Health Care | -CHF 141.6M | CHF 3.8B | CHF 34.98 | 0.19% up | 86% up | ||
| 43 | Axsome TherapeuticsAXSM · Health Care | -CHF 154.6M | CHF 6B | CHF 114.52 | 1.28% up | 6% down | ||
| 44 | Definium TherapeuticsDFTX · Health Care | -CHF 155.1M | CHF 3.4B | CHF 24.62 | 0.19% up | 168% up | ||
| 45 | Rhythm PharmaceuticalsRYTM · Health Care | -CHF 165.8M | CHF 6.9B | CHF 99.89 | 0.56% down | 18% up | ||
| 46 | Elanco Animal HealthELAN · Health Care | -CHF 195.8M | CHF 11.3B | CHF 22.59 | 0.28% up | 26% up | ||
| 47 | Ascendis PharmaASND · Health Care | -CHF 213.5M | CHF 15B | CHF 228.41 | 0.13% up | 29% up | ||
| 48 | Madrigal PharmaceuticalsMDGL · Health Care | -CHF 243.3M | CHF 7.9B | CHF 341.81 | 1.75% up | 27% down | ||
| 49 | Legend BiotechLEGN · Health Care | -CHF 250.5M | CHF 2.6B | CHF 13.48 | 1.69% down | 41% down | ||
| 50 | Roivant SciencesROIV · Health Care | -CHF 253M | CHF 24.2B | CHF 33.37 | 2.09% up | 91% up | ||
| 51 | Praxis Precision MedicinesPRAX · Health Care | -CHF 255.9M | CHF 7.6B | CHF 272.45 | 5.79% up | 86% up | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -CHF 277.6M | CHF 4.2B | CHF 23.92 | 1.92% up | 20% down | ||
| 53 | Jazz PharmaceuticalsJAZZ · Health Care | -CHF 300.5M | CHF 13.1B | CHF 204.74 | 2.07% down | 41% up | ||
| 54 | ABIVAXABVX · Health Care | -CHF 314.7M | CHF 6.3B | CHF 71.48 | 1.05% up | 32% down | ||
| 55 | Ionis PharmaceuticalsIONS · Health Care | -CHF 321.8M | CHF 3.9B | CHF 23.39 | 1.20% up | 63% down | ||
| 56 | BridgeBio PharmaBBIO · Health Care | -CHF 618.5M | CHF 13.1B | CHF 67.03 | 1.83% up | 21% up | ||
| 57 | CytokineticsCYTK · Health Care | -CHF 662.4M | CHF 6.1B | CHF 44.07 | 1.76% up | 19% down | ||
| 58 | Takeda PharmaceuticalTAK · Health Care | -CHF 805.4M | CHF 57.8B | CHF 18.09 | 0.80% up | 51% up | ||
| 59 | Summit TherapeuticsSMMT · Health Care | -CHF 911M | CHF 7.3B | CHF 9.18 | 3.62% up | 36% down | ||
| 60 | InsmedINSM · Health Care | -CHF 1.1B | CHF 23.7B | CHF 108.04 | 6.87% up | 40% down | ||
| 61 | ViatrisVTRS · Health Care | -CHF 3B | CHF 19.3B | CHF 16.83 | 1.68% down | 99% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8438 CHF).
Questions and answers
Which health care pharmaceutical companies rank first by earnings?
Johnson & Johnson (CHF 22.6B), Eli Lilly (CHF 17.4B) and Merck & Co (CHF 15.4B) are the top three of the 61 health care pharmaceutical companies ranked by earnings as of 19 Nov 2026, 15:08 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by earnings.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by earnings have a combined market value of CHF 4.21T as of 19 Nov 2026, 15:08 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by earnings”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.